<?xml version="1.0"?>
<metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:title>Editorial: Lactic acid bacteria and their bioactive compounds: key regulators of gut microbiota and immune function</dc:title><dc:creator>Fijan,	Sabina	(Avtor)
	</dc:creator><dc:creator>Connil,	Nathalie	(Avtor)
	</dc:creator><dc:creator>Bogovič Matijašić,	Bojana	(Avtor)
	</dc:creator><dc:creator>Sreenivasa,	Marikunte Yanjarappa	(Avtor)
	</dc:creator><dc:creator>Anandharaj,	Marimuthu	(Avtor)
	</dc:creator><dc:subject>lactic acid bacteria</dc:subject><dc:subject>probiotics</dc:subject><dc:subject>gut microbiota</dc:subject><dc:subject>health</dc:subject><dc:subject>bacteria</dc:subject><dc:subject>fungi</dc:subject><dc:description>This Research Topic aimed to compile articles focusing on new insights into the role of lactic acid bacteria in the regulation of the gut microbiota. The main objectives included were understanding how LAB influence gut microbiota composition, identifying bioactive compounds produced by LAB and their effects, elucidating the molecular mechanisms underlying LAB's impact on immunity, pathogen exclusion, and intestinal barrier function, and exploring potential therapeutic interventions involving LAB. By addressing these questions, the research was aimed to fill existing gaps in our knowledge and provide a comprehensive understanding of LAB's multifaceted roles in gut health and beyond.</dc:description><dc:publisher>Frontiers</dc:publisher><dc:date>2025</dc:date><dc:date>2025-11-03 15:47:38</dc:date><dc:type>Znanstveno delo</dc:type><dc:identifier>95873</dc:identifier><dc:identifier>UDK: 579.8:613.292</dc:identifier><dc:identifier>COBISS_ID: 255695619</dc:identifier><dc:identifier>DOI: 10.3389/fmicb.2025.1720803</dc:identifier><dc:identifier>ISSN pri članku: 1664-302X</dc:identifier><dc:language>sl</dc:language></metadata>
